FDA Adverse Event Malfunction Summary report: N

PCS2

MDR report key: 2211650 · Received August 5, 2011

Report

Report Number
1219343-2011-00102
Event Type
Malfunction
Date Received
August 5, 2011
Date of Event
May 19, 2011
Report Date
August 5, 2011
Manufacturer
HAEMONETICS CORP.
Product Code
JJX
PMA / PMN Number
BK040025
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

A CUSTOMER CONTACTED HAEMONETICS ON (B)(6) 2011 AND ALLEGED POSSIBLE HEMOLYSIS ON THE PLASM COLLECTION SYSTEM DURING THE FIRST DRAW CYCLE. THE OPERATOR HEARD HIGH PITCHED NOISE FROM BOWL AND NOTICED FOAMY RED CELLS GOING INTO THE PLASMA BOTTLE. THE PROCEDURE WAS TERMINATED AND NO CELLS WERE RETURNED TO THE DONOR. NO DONOR INJURY OR REACTION REPORTED. NO OPERATOR INJURY REPORTED. THE DEVICE WAS EVALUATED IN THE FIELD BY HAEMONETICS ON (B)(6) 2011. THE FIELD SERVICE ENGINEER FOUND THE DEVICE TO BE WORKING ACCORDING TO PERFORMANCE SPECIFICATIONS. NO DISPOSABLE SAMPLES WERE AVAILABLE FOR EVALUATION. NO NON-CONFORMITIES FOUND IN THE REVIEW OF HISTORICAL RECORDS FOR THE DISPOSABLES. THE SOLUTIONS USED DURING THE PROCEDURE WERE NOT MADE BY OR FOR HAEMONETICS. HEMOLYSIS WAS NOT CONFIRMED BY THE CUSTOMER. NO BLOOD SAMPLE WAS AVAILABLE FOR ANALYSIS. THE OPERATOR MADE THEIR DETERMINATION OF HEMOLYSIS BASED ON EXPERIENCE. THE RETURN OF HEMOLYZED CELLS IS DEPENDENT ON AN OPERATOR'S AWARENESS OF THE ISSUE AND TERMINATING THE PROCEDURE PRIOR TO RETURNING CELLS. THE IMPACT OF HEMOLYZED CELLS ON A HEALTHY DONOR COULD RANGE FROM NO SYMPTOMS TO ACUTE. AS THE OPERATOR TERMINATED THE PROCEDURE, THERE IS NO POTENTIAL INJURY TO THE DONOR FROM HEMOLYSIS.

Description of Event or Problem · 1

A CUSTOMER CONTACTED HAEMONETICS ON (B)(6) 2011 AND ALLEGED POSSIBLE HEMOLYSIS ON THE PLASMA COLLECTION SYSTEM DURING THE FIRST DRAW CYCLE. THE OPERATOR HEARD HIGH PITCHED NOISE FROM BOWL AND NOTICED FOAMY RED CELLS GOING INTO THE PLASMA BOTTLE. THE PROCEDURE WAS TERMINATED AND NO CELLS WERE RETURNED TO THE DONOR. NO DONOR INJURY OR REACTION REPORTED. NO OPERATOR INJURY REPORTED. AS THE PROCEDURE WAS TERMINATED, THE DONOR EXPERIENCED A RED CELL LOSS. AS THE DONOR PASSED THE HEALTH CRITERIA TO DONATE, THERE IS A VERY LOW RISK OF ANEMIA REQUIRING MEDICAL INTERVENTION. THIS CONDITION WOULD NOT BE CONSIDERED POTENTIALLY SERIOUS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PCS2 PLASMA COLLECTION SYSTEM JJX HAEMONETICS CORP. NA

Patients

Seq Age Sex Outcome Treatment
1 NI